Showing posts with label prostate cancer. Show all posts
Showing posts with label prostate cancer. Show all posts

Friday, 4 March 2011

Hair loss signals prostate cancer risk

Men with prostate cancer may be twice more likely to have started showing signs of male pattern baldness at the age of 20 years than those without prostate cancer.

Until now there has been conflicting evidence about the link between balding and prostate cancer; this is the first study to suggest a link between going bald at the young age of 20 and the development of prostate cancer in later life.

Male pattern baldness (androgenic alopecia) is very common, affecting about half of all men at some point in their lives. Its onset has previously been linked to the conversion of testosterone to androgenic hormones, and androgens have also been previously implicated in the onset and growth of prostate cancer. The drug Propecia - used to treat baldness - blocks the conversion of testosterone to an androgen thought to cause hair loss, and the drug has also been demonstrated to lower the incidence of prostate cancer.

To explore the possible connection between balding patterns and prostate cancer, researchers spent more than two years analysing disease progression and hair loss patterns in 388 men with prostate cancer in Paris. The men were diagnosed between the ages of 46 and 84 years. Starting in 2004, the study participants answered a questionnaire about their personal history of prostate cancer (if any) and to indicate on four pictures any balding patterns that they had at ages 20, 30 and 40. The pictures showed four stages of hair loss: no balding (stage I), frontal hair loss (receding hairline around the temples), vertex hair loss (a round bald patch at the top of the head), or a combination of both types of hair loss (stage IV). The men's doctors were also asked to provide a medical history of their patients, including any diagnosis of prostate cancer, age at diagnosis, stage of the disease and treatment.  Another 281 healthy men were enlisted in the study for comparison. The study ran for 28 months.

It was found that 37 of the prostate cancer patients (and 14 of the healthy men) had experienced some form of hair loss at the age of 20 years, ranging from a receding hairline to a bald patch at the top of the head, or a combination of both. Any form of hair loss at age 20 years was linked to a doubling of prostate cancer risk, the study authors reported. Men who start losing their hair in their 30s or 40s did not appear to face a similar boost in prostate cancer risk. And those whose hair loss started in their 20s did not face a higher risk of developing the cancer at an early age or of developing more aggressive tumours. The study found no association between early hair loss and an earlier diagnosis of prostate cancer, and nor was there any link between the pattern of hair loss and the development of cancer. Whether or not men who experience youthful hair loss may benefit from prostate cancer screening is yet to be determined.

The researchers cautioned, however, that it is premature to conclude that baldness and prostate cancer are, in fact, linked. Noting that androgens associated with hair loss are also associated with prostate cancer, the researchers called for more studies to see whether interventions might be appropriate for men with very early balding. Physicians need to know who could be targeted for screening and also considered for chemo-prevention using anti-androgenic drugs.

Friday, 10 September 2010

Good news for bald men at last: Hair loss 'almost halves the risk of prostate cancer'


One thing that men any age don't really want to see in the mirror is bald bald patches and receding hair lines. But research suggests those who, like Wayne Rooney, are facing a future with less hair should stop fretting at that retreating hairline and slapping on the propecia.




Men who start going bald at a young age are up to 45 per cent less likely to fall victim to prostate cancer later in life, scientists have found.


Although half of all men suffer significant hair loss by the age of 50, an American team has linked the high levels of testosterone in those who go bald earlier to a lower risk of tumours.


The scientists studied 2,000 men aged between 40 and 47, half of whom had suffered prostate cancer. They compared the rate of tumours in those who remembered their hair thinning by the age of 30 with those who did not suffer hair loss.

Men who had started to develop bald spots on the top of their heads as well as receding hairlines had the least risk of cancer.


'At first, the findings were surprising,' said Professor Jonathan Wright, an expert in prostate cancer at the University of Washington School of Medicine in Seattle. 'But we found that early onset baldness was associated with a 29 per cent to 45 per cent reduction in their relative risk of prostate cancer.'


Dr Helen Rippon, head of research management at The Prostate Cancer Charity, said: 'If these results are correct, they could be useful in providing us with a greater understanding of how testosterone behaves in the body and how it can affect different tissues.'